A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 895
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NSTE-ACS
Long Form : non-ST-segment elevation acute coronary syndrome
No. Year Title Co-occurring Abbreviation
2023 Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. NSTEMI
2023 Implementation of the ESC 0 h/1 h high-sensitivity troponin algorithm for decision-making in the emergency department. hs-cTn
2022 A Comparison Between Two-Dimensional and Three-Dimensional Regional and Global Longitudinal Strain Echocardiography to Evaluate Complex Coronary Lesions in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. ECG, GCS, GLS, GRS, HbA1c, LAD, LCX, LM, STE, TTE
2022 A Left Atrial Myxoma Masquerading As Acute Coronary Syndrome. ECGs
2022 A systematic review and meta-analysis of percutaneous coronary intervention compared to coronary artery bypass grafting in non-ST-elevation acute coronary syndrome. CABG, CI, IRR, MACE, PCI
2022 Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study. GRACE, IDI, NRI, PCI, TyG index
2022 An international, stepped wedge, cluster-randomized trial investigating the 0/1-h algorithm in suspected acute coronary syndrome in Asia: the rational of the DROP-Asian ACS study. ED, hs-cTn, MACE
2022 Application of Layered Strain Technique in NSTE-ACS. GCS, GLS, ROC, TLS, TnI
2022 Assessment of Myocardial Work of the Left Ventricle before and after PCI in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome by Pressure-Strain Loop Technology. GLS, LVEF, PCI, PSL
10  2022 Association of baseline hemoglobin A1c levels with bleeding in patients with non-ST-segment elevation acute coronary syndrome underwent percutaneous coronary intervention: insights of a multicenter cohort study from China. CI, HbA1c, HR, PCI
11  2022 Association of Prolonged Emergency Department Length of Stay with Adverse Events in Patients with Non-ST-Elevation Acute Coronary Syndrome. CHF, ED, EDLOS, ESC, TIA
12  2022 Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation AcuteCoronary Syndromes. CTSS, CV
13  2022 Comparison of invasive treatment strategies in patients with non-ST elevation acute coronary syndrome: A systematic review and meta-analysis. CABG, CI, HRs, PCI, RCTs, RMST
14  2022 Comparison of Outcomes for Non-ST Elevation Acute Myocardial Infarction in Weekday vs Weekend Admissions: The Weekend Effect. ACS, EF, LOS
15  2022 Coronary Computed Tomography Angiographic Predictors of Non-culprit Territory Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance in Non-ST-elevation Acute Coronary Syndrome. CCTA, CI, CMR, EFA, EFV, FAI, LGE, non-IR, PCI, UMI
16  2022 Coronary CT and timing of invasive coronary angiography in patients ≥75 years old with non-ST segment elevation acute coronary syndromes. CAD, CCTA, ICA, NPV
17  2022 Coronary-specific quantification of myocardial deformation by strain echocardiography may disclose the culprit vessel in patients with non-ST-segment elevation acute coronary syndrome. CAD, Cx, ICA, LAD, RCAs, TLS, WMSI
18  2022 Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome. CI, cm, continuous-NRI, eGDR, IDI, IR, ISR, ORs, PCI, ROC
19  2022 Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome. QALYs
20  2022 Current management of non ST elevation acute coronary syndrome (NSTE-ACS). ---
21  2022 Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany. AF, DAT, NOACs, PCI, TAT
22  2022 Development and Internal Validation of a Practical Model to Identify Observe Patients of the European Society of Cardiology 0/1-h Algorithm at Low Risk of a Coronary Diagnosis. CAD, CI, ED, ESC
23  2022 Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention. C-statistic, CI-AKI, DCA, PCI
24  2022 Differential Association Between Significant Coronary Stenosis and Cardiac Troponin T Serial Algorithms in Chronic Kidney Disease Patients Diagnosed with Non-ST-Segment Elevation Acute Coronary Syndromes. CKD, hr, hs-cTnT
25  2022 Dynamic changes in electrocardiographic findings between initial and follow-up electrocardiography: The role of the T/QRS ratio. ECGs
26  2022 Early vs. Delayed Initiation of Treatment With P2Y12 Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. HR, MACEs
27  2022 Effect of different revascularization times on intermediate-risk non-ST-elevation acute coronary syndrome. MACEs, TIMI
28  2022 Effect of Qingre Jiedu Huoxue Huayu Recipe on blood stasis and toxin syndrome in patients with non-ST segment elevation acute coronary syndrome, serum Lp-PLA2, TNF- alpha, and PIGF expression level. Lp-PLA2, TNF-alpha
29  2022 Effects of TCFA on stent neointimal coverage at 9months after EXCEL drug-eluting stent implantation assessed by OCT. OCT, TCFAs
30  2022 Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial. CK, CK-MB, cTnI, SAQ, SQSX
31  2022 Electrocardiography Score for Left Ventricular Systolic Dysfunction in Non-ST Segment Elevation Acute Coronary Syndrome. AUC, ECG, GRACE, LV, LVEF, TIMI
32  2022 Elevated levels of sIL-2R, TNF-alpha and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome. CI, CSF, CTFC, hs-CRP, IL-1ss, OR, PCI, sIL-2R, TNF-alpha
33  2022 Elevated TyG Index Predicts Incidence of Contrast-Induced Nephropathy: A Retrospective Cohort Study in NSTE-ACS Patients Implanted With DESs. CIN, DESs, ROC, TyG
34  2022 Epidemiological-clinical and paraclinical particularities of acute coronary syndrome without persistent ST-segment elevation in type 2 diabetes mellitus: Retrospective comparative study in a Malagasy population. T2DM
35  2022 Fibrinogen-to-Albumin Ratio Predicts Postcontrast Acute Kidney Injury in Patients with Non-ST Elevation Acute Coronary Syndrome after Implantation of Drug-Eluting Stents. DESs, FAR, PC-AKI, ROC, SCr
36  2022 Gender Particularities and Prevalence of Atypical Clinical Presentation in Non-ST Elevation Acute Coronary Syndrome. NSTEMI, UA
37  2022 Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients undergoing invasive care. aHR, CCI
38  2022 Impact of the COVID-19 pandemic on percutaneous coronary interventions in Portugal. CCS, PCIs, RNCI, STEMI
39  2022 Implementation of High-Sensitivity Cardiac Troponin Assays in the United States. hs-cTn
40  2022 Incorporation of Serial 12-Lead Electrocardiogram With Machine Learning to Augment the Out-of-Hospital Diagnosis of Non-ST Elevation Acute Coronary Syndrome. AUC, ECG, NSTE
41  2022 Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease. CABG, CI, HR, MACCEs, PCI, TVD
42  2022 Invasive treatment strategy in patients aged 80 years or older with non-ST-elevation acute coronary syndromes: a retrospective cohort study. ---
43  2022 Management and Outcomes in the Elderly with Non-ST-Elevation Acute Coronary Syndromes Admitted to Spoke Hospitals with No Catheterization Laboratory Facility. cath lab
44  2022 Meta-analysis Comparing Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting for Non-ST Elevation Acute Coronary Syndrome in Patients With Multivessel or Left Main Disease. CABG, CAD, CI, MACE, MVD, PCI, RR
45  2022 Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome. CO-PCI, MI, MVD, TVR
46  2022 Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-2020. ACS, PPCI, STEMI, TLT
47  2022 Non-ST-elevation acute coronary syndrome in chronic kidney disease: prognostic implication of an early invasive strategy. CKD, eGFR, HR, PCI, RR
48  2022 One-Year Ischemic and Bleeding Events According to Renal Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Third-Generation Antiplatelet Drugs. CI, CKD, eGFR, HR, PCI
49  2022 Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention. CABG, CI, continuous-NRI, eGDR, HR, IDI, IR, MACCEs, PCI, ROC, T2DM
50  2022 Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis. EMS, MACE
51  2022 Prehospital triage of patients with suspected non-ST-segment elevation acute coronary syndrome: Rationale and design of the TRIAGE-ACS study. ED
52  2022 Pretreatment with a P2Y12 receptor inhibitor and delay to coronary artery bypass surgery in patients with non-ST segment elevation acute coronary syndrome. CABG, P2Y12i
53  2022 Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. CI, continuous-NRI, GA, HR, IDI, MACCEs, PCI
54  2022 Rationale and design of COLchicine On-admission to Reduce inflammation in Acute Coronary Syndrome (COLOR-ACS) study. COLOR-ACS, hs-CRP
55  2022 Role and relevance of risk stratification models in the modern-day management of non-ST elevation acute coronary syndromes. ---
56  2022 Routine Invasive Strategy in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Trials. CI, RCT, RR
57  2022 Same day discharge following non-elective PCI for non-ST elevation acute coronary syndromes. LOS, NDD, PCI, SDD
58  2022 Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation. AUC, GRACE
59  2022 The effect of weekends and public holidays on the care of acute coronary syndrome in the Spanish National Health System. PCI, STEMI, WHA
60  2022 The guiding value of hybrid resting full-cycle ratio and fractional flow reserve strategy for percutaneous coronary intervention in a Chinese real-world cohort with non-ST elevation acute coronary syndrome. FFR, PCI, RFR, ROC
61  2022 Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry. CI
62  2022 Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials. CI, HF, IS, MI, RCTs, RR, RR, RR, RRs
63  2022 Troponin I Cutoff for Non-ST-Segment Elevation Myocardial Infarction in Sepsis. AUC, GRACE, MI, NSTEMI
64  2021 A new iteration for the single-access large-bore technique during Impella supported complex and high-risk coronary intervention: a case report. ACS, CP
65  2021 ACEF performed better than other risk scores in non-ST-elevation acute coronary syndrome during long term follow-up. MACE
66  2021 An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial. AUC, HR, MACE
67  2021 Angiography-derived index of microcirculatory resistance (IMRangio) as a novel pressure-wire-free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease. CCS, CMD, MVO, NH-IMRangio, STEMI
68  2021 Antithrombotic Strategies in Invasively Managed Patients with Non-ST Elevation Acute Coronary Syndromes and Non-Valvular Atrial Fibrillation in Romania. AF, CV, OAC, TAT
69  2021 Application of MAT Methodology in the Evaluation of Prescribing Adherence to Clinical Practice Guidelines for Secondary Prevention of Coronary Heart Disease in Post-Acute Coronary Syndrome Patients in Kuwait. CHD, MATs, STEMI
70  2021 Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis. MACEs, MI, OR
71  2021 Association of neutrophil to lymphocyte ratio (NLR) with angiographic SYNTAX score in patients with non-ST-Segment elevation acute coronary syndrome (NSTE-ACS). NLR
72  2021 Association of Parenteral Anticoagulation Therapy With Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Without Invasive Therapy: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project. CCC, CI, OR, PACT
73  2021 Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention. AUC, CI, HF, HR, MACCE, OR, PCI, sST2, STEMI
74  2021 Baseline CHA2 DS2 -VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome. AF
75  2021 Comparison of Long-Term Outcomes in Men versus Women Undergoing Percutaneous Coronary Intervention. CAD, PCI, SAP, STEMI
76  2021 Comparison of Prognostic Value Among 4 Risk Scores in Patients with Acute Coronary Syndrome: Findings from the Improving Care for Cardiovascular Disease in China-ACS (CCC-ACS) Project. ACEF, ACS, C-ACS, GRACE, STEMI
77  2021 Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus. CI, HR, IR, MACCE, PCI, T2DM, TyG
78  2021 Coronary Artery Disease Without Standard Cardiovascular Risk Factors. CCS, CI, HR, STEMI
79  2021 Coronary CT angiography for improved assessment of patients with acute chest pain and low-range positive high-sensitivity troponins: study protocol for a prospective, observational, multicentre study (COURSE trial). CCTA, ECG, hs-troponins
80  2021 Correlation Of Global Longitudinal Systolic Strain With Severity Of Coronary Artery Disease In Non-Stelevation Acute Coronary Syndrome Having Normal Ejection Fraction. CAD, GLPS, GLPS-APLEX, LMCA, LVEDD, LVEF, LVESD
81  2021 Culprit Lesion Detection in Patients Presenting With Non-ST Elevation Acute Coronary Syndrome and Multivessel Disease. MACE, MVD
82  2021 Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3. CABG, CREDO-Kyoto, PCI
83  2021 Development and validation of a risk score for chest pain with suspected non-ST-segment elevation acute coronary syndrome. ---
84  2021 Development and Validation of a Risk Score for Predicting Post-acute Myocardial Infarction Infection in Patients Undergoing Percutaneous Coronary Intervention: Study Protocol for an Observational Study. MACE, PCI, post-AMI, STEMI
85  2021 Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome. ESC, hs-cTnT, NSTEMI
86  2021 Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation. ACC, ESC
87  2021 Dropping risk stratification with subsequent treatment-risk paradox in non ST elevation acute coronary syndromes: a clinical audit in Iraq. TIMI
88  2021 Drug-Drug Interactions in Patients with COVID-19: A Retrospective Study at a Tertiary Care Hospital in Eastern India. AF, COVID-19, DDIs
89  2021 Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry. HF, HR, MACE
90  2021 Early invasive versus non-invasive assessment in patients with suspected non-ST-elevation acute coronary syndrome. ICA
91  2021 Effect of Admission Hyperglycemia on Short-Term Prognosis of Patients with Non-ST Elevation Acute Coronary Syndrome without Diabetes Mellitus. BG
92  2021 Factors associated with long-term major adverse cardiac events of coronary bioresorbable vascular scaffold. BVS, MACE, OR, PCI
93  2021 Fondaparinux versus enoxaparin in the contemporary management of non-ST-elevation acute coronary syndromes. Insights from a multicenter registry. SHR
94  2021 Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome. HRQoL
95  2021 High-Sensitivity Cardiac Troponin T in Patients with Severe Chronic Kidney Disease and Suspected Acute Coronary Syndrome. hs-cTnT
96  2021 Impact of creating a hemodynamics room, a coronary care unit, and a primary angioplasty program on the prognosis of acute coronary syndrome in a district hospital. STE-ACS
97  2021 Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. CABG, HR, HR, MACCE, OR, PCI, SCH, TSH
98  2021 Implementation of an accelerated discharge process following percutaneous coronary intervention for patients with non-ST elevation acute coronary syndromes. LOS, PCI, SDD
99  2021 Incidence, functional impact and predictive factors for the presentation of complications associated with radial access for coronary angiography evaluated through ultrasonography, hospital cohort STEMI
100  2021 International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. ACS, BCIS, COVID-19, MINAP, STEMI